This biotechnology company utilizes artificial intelligence and synthetic biology to analyze gut microbial DNA and identify molecules that can promote gut health. By targeting the aging process, the company aims to enhance overall well-being through microbiome-based interventions.
Funding
Funding not disclosed
Founders
Product
Problem
Current gut health solutions often focus on modulating the microbiome through probiotics and prebiotics, which have limitations such as inconsistent results due to diet, individual variability, and the inability of introduced bacteria to colonize effectively. These approaches often overlook the importance of gut barrier integrity and the host's immune response to the gut environment. A "healthy microbiome" lacks a clear definition, and its activity is heavily influenced by external factors.
Solution
veMico develops postbiotic solutions that strengthen gut barrier function and enhance immune resilience, enabling the body to adapt to its environment. Instead of directly modifying the microbiota composition, veMico's bioactive compounds, derived from probiotic bacteria, interact with the immune system and gut barrier to deliver consistent and predictable benefits. This host-focused approach empowers the body to adapt and thrive, addressing the shortcomings of conventional microbiome modulation strategies. veMico's solutions aim to improve overall well-being by focusing on the communication between the gut microbiota, the mucosal immune system, and pattern recognition receptors. The company's approach targets specific local immune receptors that monitor the microbiota and define systemic immune system function, providing clinically validated solutions for modern lifestyle conditions and immune-mediated diseases.
Target Audience
veMico targets individuals seeking to improve their gut health and overall well-being, as well as companies looking to develop new products or license innovative bioactives in the gut health space.
Features
- Postbiotic formulations that strengthen the gut barrier and enhance immune resilience.
- Orally delivered, food-grade, natural, anti-inflammatory products.
- Focus on the interaction between the gut microbiota, the mucosal immune system, and pattern recognition receptors (PRRs).
- Solutions that target specific local immune receptors that monitor the microbiota.
- Clinically validated products to address the impact of gut health on modern lifestyle conditions and immune system mediated diseases.